ResearcherUniversity of MinnesotaNo recent work listed

Kianna Y. Elahi-Gedwillo

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5089619707. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-18-1334 ↗
Physical and Chemical Enhancement of and Adaptive Resistance to Irreversible Electroporation of Pancreatic Cancer. Co-author DOI 10.1007/s10439-017-1932-3 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Paolo Provenzano · 2 shared papers, 2018–2019 · strength 0.23
- Paper Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/0008-5472.can-18-1334 ↗
- Paper Physical and Chemical Enhancement of and Adaptive Resistance to Irreversible Electroporation of Pancreatic Cancer. DOI 10.1007/s10439-017-1932-3 ↗
John C. Bischof · 1 shared paper, 2018 · strength 0.09
- Paper Physical and Chemical Enhancement of and Adaptive Resistance to Irreversible Electroporation of Pancreatic Cancer. DOI 10.1007/s10439-017-1932-3 ↗
Qi Shao · 1 shared paper, 2018 · strength 0.09
- Paper Physical and Chemical Enhancement of and Adaptive Resistance to Irreversible Electroporation of Pancreatic Cancer. DOI 10.1007/s10439-017-1932-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.